Altium Capital Management LLC 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:35 pm Sale | 2022-12-31 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LLC | 0 0.000% | -41,667 (Position Closed) | Filing |
| 2022-11-17 5:08 pm Purchase | 2022-11-04 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LLC | 41,667 7.700% | 41,667 (New Position) | Filing |